Fermentation with Aquilariae Lignum enhances the anti-diabetic activity of green tea in type II diabetic db/db mouse

Nutrients

Volumn 6, Issue 9, 2014, Pages 3536-3571

  Kang, Su Jin ^a   Lee, Ji Eun ^a   Lee, Eun Kyung ^a   Hwa Jung, Dae ^b   Song, Chang Hyun ^a   Park, Soo Jin ^a   Choi, Seong Hun ^a   Han, Chang Hyun ^c   Ku, Sae Kwang ^a   Lee, Young Joon ^a  

^a Daegu Haany University   (South Korea)

^b HaniBio Co   (South Korea)

^c Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

BKS.Cg +Leprdb +Leprdb OlaHsd (db db) mice; Diabetes; Fermented green tea with Aquilariae Lignum; Obese; Synergistic

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; AQUILARIAE LIGNUM EXTRACT; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATININE; GLUCOSE; GLUTATHIONE; GREEN TEA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G ANTIBODY; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; METFORMIN; PLANT EXTRACT; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZYMOGEN GRANULE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; GLUCOSE BLOOD LEVEL; LIPID;

ACCLIMATIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; FERMENTATION; FLUID INTAKE; FOOD INTAKE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY DISEASE; LIPID PEROXIDATION ASSAY; LIVER DISEASE; LIVER HYPERTROPHY; MEASUREMENT; MORPHOMETRICS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORGAN WEIGHT; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET CELL HYPERPLASIA; TEA; TISSUE HOMOGENATE; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; BLOOD; CAMELLIA SINENSIS; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; INBRED MOUSE STRAIN; METABOLISM; PHYTOTHERAPY; THYMELAEACEAE;

MUS;

ADIPOSE TISSUE; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; CAMELLIA SINENSIS; DIABETES MELLITUS, TYPE 2; FEMALE; FERMENTATION; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIPIDS; MICE, INBRED STRAINS; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; THYMELAEACEAE;

EID: 84907198382     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6093536     Document Type: Article

References (60)

1. Warren R.E. The stepwise approach to the management of type 2 diabetes. Diabetes Res. Clin. Pract. 2004, 65, S3–S8.
2. DeFronzo, R.A. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 1999, 131, 281–303.
3. Postic C.; Girard, J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice. J. Clin. Investig. 2008, 118, 829–838.
4. Bonnard C.; Durand, A.; Peyrol, S.; Chanseaume, E.; Chauvin, M.A.; Morio, B.; Vidal, H.; Rieusset, J. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Investig. 2008, 118, 789–800.
5. Mahesh T.; Menon, V.P. Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats. Phytother. Res. 2004, 18, 123–127.
6. Yki-Jarvinen, H. Glucose toxicity. Endocr. Rev. 1992, 13, 415–431.
7. Bonner-Weir, S. Life and death of the pancreatic beta cells. Trends Endocrinol. Metab. 2000, 11, 375–378.
8. Wendel A.A.; Purushotham, A.; Liu, L.F.; Belury, M.A. Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice. J. Lipid Res. 2008, 49, 98–106.
9. Van Kruijsdijk R.C.; van der Wall, E.; Visseren, F.L. Obesity and cancer: The role of dysfunctional adipose tissue. Cancer Epidemiol. Biomark. Prev. 2009, 18, 2569–2578.
10. Sakaue H.; Nishizawa, A.; Ogawa, W.; Teshigawara, K.; Mori, T.; Takashima, Y.; Noda, T.; Kasuga, M. Requirement for 3-phosphoinositide-kependent dinase-1 (pdk-1) in insulin-induced glucose uptake in immortalized brown adipocytes. J. Biol. Chem. 2003, 278, 38870–38874.
11. Chen H.; Qu, Z.; Fu, L.; Dong, P.; Zhang X. Physicochemical properties and antioxidant capacity of 3 polysaccharides from green tea, oolong tea, and black tea. J. Food Sci. 2009, 74, C469–C474.
12. Zhu Q.Y.; Hackman, R.M.; Ensunsa, J.L.; Holt, R.R.; Keen, C.L. Antioxidative activities of oolong tea. J. Agric. Food Chem. 2002, 50, 6929–6934.
13. Lu N.; Chen P.; Yang, Q.; Peng, Y.Y. Anti- and pro-oxidant effects of (+)-catechin on hemoglobin-induced protein oxidative damage. Toxicol. In Vitro 2011, 25, 833–838.
14. Bhattacharyya A.; Mandal, D.; Lahiry, L.; Sa, G.; Das, T. Black tea protects immunocytes from tumor-induced apoptosis by changing bcl-2/bax ratio. Cancer Lett. 2004, 209, 147–154.
15. Curin Y.; Andriantsitohaina, R. Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol. Rep. 2005, 57, 97–107.
16. Hodgson J.M.; Burke, V.; Puddey, I.B. Acute effects of tea on fasting and postprandial vascular function and blood pressure in humans. J. Hypertens. 2005, 23, 47–54.
17. Weber J.M.; Ruzindana-Umunyana, A.; Imbeault, L.; Sircar, S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiv. Res. 2003, 58, 167–173.
18. Anderson R.A.; Polansky, M.M. Tea enhances insulin activity. J. Agric. Food Chem. 2002, 50, 7182–7186.
19. Yin J.; Guo, L. Modern Research and Clinical Applications of Chinese Materia Medica; Chinese Medical Classics Press: Beijing, China, 1995.
20. Kim Y.C.; Lee E.H.; Lee Y.M.; Kim H.K.; Song, B.K.; Lee E.J.; Kim H.M. Effect of the aqueous extract of Aquilaria agallocha stems on the immediate hypersensitivity reactions. J. Ethnopharmacol. 1997, 58, 31–38.
21. Okugawa H.; Ueda, R.; Matsumoto, K.; Kawanishi, K.; Kato, A. Effect of jinkoh-eremol and agarospirol from agarwood on the central nervous system in mice. Planta Med. 1996, 62, 2–6.
22. Zhang Y.; Wang, W.; Zhang J. Effects of novel anxiolytic 4-butyl-alpha-agarofuran on levels of monoamine neurotransmitters in rats. Eur. J. Pharmacol. 2004, 504, 39–44.
23. Park J.H.; Kim Y.; Kim S.H. Green tea extract (Camellia sinensis) fermented by Lactobacillus fermentum attenuates alcohol-induced liver damage. Biosci. Biotechnol. Biochem. 2012, 76, 2294–2300.
24. Ku S.K. Preliminary Effects of Aquilariae Lignum-Fermented Green Tea Extracts (fGT) on Type II Diabetic, db/db Mouse; Daegu Haany University: Gyeongsan, Korea, 2013; pp. 1–41.
25. Sahai A.; Malladi, P.; Pan, X.; Paul, R.; Melin-Aldana, H.; Green, R.M.; Whitington, P.F. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: Role of short-form leptin receptors and osteopontin. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287, G1035–G1043.
26. Kavutcu M.; Canbolat, O.; Ozturk, S.; Olcay, E.; Ulutepe, S.; Ekinci, C.; Gokhun, I.H.; Durak, I. Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: Effects of vitamins E and C. Nephron 1996, 72, 269–274.
27. Jamall I.S.; Smith, J.C. Effects of cadmium on glutathione peroxidase, superoxide dismutase, and lipid peroxidation in the rat heart: A possible mechanism of cadmium cardiotoxicity. Toxicol. Appl. Pharmacol. 1985, 80, 33–42.
28. Lowry O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265–275.
29. Sedlak J.; Lindsay, R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem. 1968, 25, 192–205.
30. Aebi H. Catalase. In Methods of Enzymatic Analysis; Bergmeyer, H., Ed.; Academic Press: New York, NY, USA, 1974; pp. 673–686.
31. Sun Y.; Oberley, L.W.; Li, Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34, 497–500.
32. Folch J.; Lees, M.; Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497–509.
33. McGowan, M.W.; Artiss, J.D.; Strandbergh, D.R.; Zak, B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 1983, 29, 538–542.
34. Kawakami S.; Han, K.H.; Nakamura, Y.; Shimada, K.; Kitano, T.; Aritsuka, T.; Nagura, T.; Ohba, K.; Nakamura, K.; Fukushima, M. Effects of dietary supplementation with betaine on a nonalcoholic steatohepatitis (NASH) mouse model. J. Nutr. Sci. Vitaminol. 2012, 58, 371–375.
35. Kim J.D.; Kang, S.M.; Park M.Y.; Jung T.Y.; Choi, H.Y.; Ku S.K. Ameliorative anti-diabetic activity of dangnyosoko, a Chinese herbal medicine, in diabetic rats. Biosci. Biotechnol. Biochem. 2007, 71, 1527–1534.
36. Edwin N.; Leigh, C.M. Immunocytochemical identification of islet cells containing calcitonin gene-related peptide-like immunoreactivity in the plains rat pancreas (Pseudomys australis). Singap. Med. J. 1999, 40, 528–530.
37. Lee H.S.; Chang, J.H.; Ku S.K. An immunohistochemical study of the pancreatic endocrine cells of the ddN mouse. Folia Histochem. Cytobiol. 2010, 48, 387–393.
38. Sabu M.C.; Smitha, K.; Kuttan, R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J. Ethnopharmacol. 2002, 83, 109–116.
39. Sharma K.; McCue, P.; Dunn, S.R. Diabetic kidney disease in the db/db mouse. Am. J. Physiol. Renal Physiol. 2003, 284, F1138–F1144.
40. Morange P.E.; Lijnen, H.R.; Alessi, M.C.; Kopp, F.; Collen, D.; Juhan-Vague, I. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1150–1154.
41. Bjorbaek C.; Kahn, B.B. Leptin signaling in the central nervous system and the periphery. Recent Progr. Horm. Res. 2004, 59, 305–331.
42. Maeda K.; Okubo, K.; Shimomura, I.; Funahashi, T.; Matsuzawa, Y.; Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 1996, 221, 286–289.
43. Mitchell M.; Armstrong, D.T.; Robker, R.L.; Norman, R.J. Adipokines: Implications for female fertility and obesity. Reproduction 2005, 130, 583–597.
44. Matsubara M. Plasma adiponectin decrease in women with nonalcoholic fatty liver. Endocr. J. 2004, 51, 587–593.
45. Maebuchi M.; Machidori, M.; Urade, R.; Ogawa, T.; Moriyama, T. Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: Development of an ELISA system for quantification of resistin. Arch. Biochem. Biophys. 2003, 416, 164–170.
46. Guerre-Millo, M. Extending the glucose/fatty acid cycle: A glucose/adipose tissue cycle. Biochem. Soc. Trans. 2003, 31, 1161–1164.
47. Wilson J.S.; Korsten, M.A.; Leo, M.A.; Lieber, C.S. Combined effects of protein deficiency and chronic ethanol consumption on rat pancreas. Dig. Dis. Sci. 1988, 33, 1250–1259.
48. Gartner L.P.; Hiatt, J.L. Colour Textbook of Histology, 3rd ed.; WB Saunders: Philadelphia, PA, USA, 2007.
49. Snedeker S.M.; Hay, A.G. Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ. Health Perspect. 2012, 120, 332–339.
50. Terauchi Y.; Takamoto, I.; Kubota, N.; Matsui, J.; Suzuki, R.; Komeda, K.; Hara, A.; Toyoda, Y.; Miwa, I.; Aizawa, S. et al. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J. Clin. Investig. 2007, 117, 246–257.
51. Kawashima S.; Matsuoka, T.A.; Kaneto, H.; Tochino, Y.; Kato, K.; Yamamoto, K.; Yamamoto, T.; Matsuhisa, M.; Shimomura, I. Effect of alogliptin, pioglitazone and glargine on pancreatic beta-cells in diabetic db/db mice. Biochem. Biophys. Res. Commun. 2011, 404, 534–540.
52. Kim C.M.; Yi, S.J.; Cho, I.J.; Ku S.K. Red-koji fermented red ginseng ameliorates high fat diet-induced metabolic disorders in mice. Nutrients 2013, 5, 4316–4332.
53. Sodikoff C.H. Laboratory Profiles of Small Animal Diseases: A Guide to Laboratory Diagnosis; Mosby Inc.: Maryland Heights, MO, USA, 1995.
54. Garg M.C.; Singh, K.P.; Bansal, D.D. Effect of vitamin C supplementation on oxidative stress in experimental diabetes. Indian J. Exp. Biol. 1997, 35, 264–266.
55. Ceriello A.; Quatraro, A.; Giugliano D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet. Med. 1992, 9, 297–299.
56. Collier A.; Wilson R.; Bradley, H.; Thomson, J.A.; Small, M. Free radical activity in type 2 diabetes. Diabet. Med. 1990, 7, 27–30.
57. Giugliano D.; Ceriello A.; Paolisso, G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19, 257–267.
58. Comporti M. Lipid peroxidation and cellular damage in toxic liver injury. Lab. Invest. 1985, 53, 599–623.
59. Jung U.J.; Park Y.B.; Kim S.R.; Choi, M.S. Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice. PLoS One 2012, 7, e49030, doi:10.1371/journal.pone.0049030.
60. Odabasoglu F.; Cakir, A.; Suleyman, H.; Aslan, A.; Bayir, Y.; Halici, M.; Kazaz, C. Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats. J. Ethnopharmacol. 2006, 103, 59–65.